Search

Your search keyword '"Harris, Marianne"' showing total 519 results

Search Constraints

Start Over You searched for: Author "Harris, Marianne" Remove constraint Author: "Harris, Marianne"
519 results on '"Harris, Marianne"'

Search Results

1. Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size

2. Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi’omics profiling

4. Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)

5. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

6. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

7. DNA Methylation Demonstrates Bronchoalveolar Cell Senescence in People Living with HIV: An Observational Cohort Study

8. The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study

10. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

11. Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

12. T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy

13. Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

14. Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada

18. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

19. Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

20. HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

21. 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine

22. Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size

23. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

25. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

26. 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.

27. Baseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV.

30. Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs

31. Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)—CTN 314

32. HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine

33. Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART

34. COVID-19 vaccine immunogenicity in people with HIV

35. Additional file 1 of Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi’omics profiling

36. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

37. List of Contributors

40. Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease

41. People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

42. Salvage therapy

43. AIDS in the Intensive Care Unit

44. A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

45. Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy

46. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses

49. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

Catalog

Books, media, physical & digital resources